| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Oct-11 4:54 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 21-Oct-11 | Market Sale | 364,918 | $3.68 | $1,342,900.00 | (7%) 5.52M to 5.15M | 0% |
| 24-Oct-11 4:54 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 20-Oct-11 | Market Sale | 5,252,700 | $3.68 | $19,329,900.00 | (49%) 10.77M to 5.52M | 0% |
| 19-Oct-11 4:08 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 17-Oct-11 | Market Sale | 650,100 | $3.68 | $2,392,370.00 | (6%) 11.42M to 10.77M | (< 1%) |
| 28-Sep-11 1:18 PM View: ![]() | Inhibitex Inc. (INHX) | 27-Sep-11 | Market Sale | 200,000 | $3.00 | $600,000.00 | (3%) 7.9M to 7.7M | |
| 28-Sep-11 1:18 PM View: ![]() | Inhibitex Inc. (INHX) | 26-Sep-11 | Market Sale | 33,900 | $2.98 | $100,965.00 | (< 1%) 7.93M to 7.9M | |
| 09-Jun-11 5:01 PM View: ![]() | Medivation, Inc. (MDVN) | 07-Jun-11 | Market Sale | 368,147 | $22.62 | $8,329,090.00 | (10%) 3.7M to 3.33M | (350%) |
| 06-Jun-11 7:30 PM View: ![]() | Medivation, Inc. (MDVN) | 06-Jun-11 | Market Sale | 127,834 | $22.21 | $2,838,790.00 | (3%) 3.83M to 3.7M | (358%) |
| 06-Jun-11 7:30 PM View: ![]() | Medivation, Inc. (MDVN) | 03-Jun-11 | Market Sale | 90,169 | $22.68 | $2,045,360.00 | (2%) 3.92M to 3.83M | (348%) |
| 06-Jun-11 7:30 PM View: ![]() | Medivation, Inc. (MDVN) | 02-Jun-11 | Market Sale | 50,752 | $22.84 | $1,158,930.00 | (1%) 3.97M to 3.92M | (345%) |
| 02-Jun-11 8:28 PM View: ![]() | Inhibitex Inc. (INHX) | 31-May-11 | Market Sale | 655,000 | $4.50 | $2,945,900.00 | (8%) 8.59M to 7.93M | 3% |
| 11-Apr-11 7:16 PM View: ![]() | Inhibitex Inc. (INHX) | 11-Apr-11 | Market Sale | 139,052 | $4.29 | $595,926.00 | (2%) 8.73M to 8.59M | < 1% |
| 11-Apr-11 7:16 PM View: ![]() | Inhibitex Inc. (INHX) | 08-Apr-11 | Market Sale | 335,382 | $4.38 | $1,467,730.00 | (4%) 9.06M to 8.73M | 2% |
| 11-Apr-11 7:16 PM View: ![]() | Inhibitex Inc. (INHX) | 07-Apr-11 | Market Sale | 129,757 | $4.52 | $586,502.00 | (1%) 9.19M to 9.06M | 6% |
| 05-Jan-11 6:44 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 03-Jan-11 | Market Purchase | 34,209 | $1.41 | $48,234.70 | < 1% 11.39M to 11.42M | 163% |
| 04-Jan-11 7:03 PM View: ![]() | TPC Group Inc (TPCG) | 31-Dec-10 | Market Sale | 14,000 | $30.77 | $430,780.00 | (< 1%) 2.72M to 2.71M | (38%) |
| 03-Jan-11 6:04 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 30-Dec-10 | Market Purchase | 300 | $1.48 | $444.00 | < 1% 11.39M to 11.39M | 161% |
| 03-Jan-11 6:04 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 29-Dec-10 | Market Purchase | 317,014 | $1.45 | $460,170.00 | 3% 11.07M to 11.39M | 166% |
| 29-Dec-10 7:30 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 28-Dec-10 | Market Purchase | 544,690 | $1.44 | $783,134.00 | 5% 10.52M to 11.07M | 168% |
| 29-Dec-10 7:30 PM View: ![]() | TPC Group Inc (TPCG) | 28-Dec-10 | Market Sale | 24,600 | $30.78 | $757,188.00 | (< 1%) 2.74M to 2.72M | (38%) |
| 29-Dec-10 7:30 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 27-Dec-10 | Market Purchase | 1,714,210 | $1.30 | $2,228,470.00 | 19% 8.81M to 10.52M | 197% |
| 29-Dec-10 7:30 PM View: ![]() | TPC Group Inc (TPCG) | 27-Dec-10 | Market Sale | 49,000 | $30.85 | $1,511,650.00 | (2%) 2.79M to 2.74M | (38%) |
| 27-Dec-10 4:55 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 23-Dec-10 | Market Purchase | 285,790 | $1.21 | $345,806.00 | 3% 8.52M to 8.81M | 219% |
| 01-Dec-10 5:18 PM View: ![]() | Medivation, Inc. (MDVN) | 29-Nov-10 | Market Purchase | 200 | $11.00 | $2,200.00 | < 1% 3.97M to 3.97M | 845% |
| 26-Nov-10 2:20 PM View: ![]() | Medivation, Inc. (MDVN) | 23-Nov-10 | Market Purchase | 2,100 | $10.99 | $23,079.00 | < 1% 3.97M to 3.97M | 846% |
| 19-Nov-10 4:47 PM View: ![]() | Medivation, Inc. (MDVN) | 17-Nov-10 | Market Purchase | 400 | $11.00 | $4,400.00 | < 1% 3.97M to 3.97M | 845% |
| 28-Oct-10 7:31 PM View: ![]() | Medivation, Inc. (MDVN) | 27-Oct-10 | Market Purchase | 14,901 | $11.42 | $170,169.00 | < 1% 3.95M to 3.97M | 811% |
| 28-Oct-10 7:31 PM View: ![]() | Medivation, Inc. (MDVN) | 26-Oct-10 | Market Purchase | 40,914 | $11.44 | $468,056.00 | 1% 3.91M to 3.95M | 809% |
| 26-Oct-10 7:21 PM View: ![]() | Medivation, Inc. (MDVN) | 25-Oct-10 | Market Purchase | 22,726 | $11.28 | $256,349.00 | < 1% 3.89M to 3.91M | 822% |
| 26-Oct-10 7:21 PM View: ![]() | Medivation, Inc. (MDVN) | 22-Oct-10 | Market Purchase | 134,470 | $11.28 | $1,516,800.00 | 4% 3.75M to 3.89M | 822% |
| 22-Oct-10 4:55 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 20-Oct-10 | Market Purchase | 150,000 | $1.65 | $247,500.00 | 2% 8.37M to 8.52M | 133% |
| 19-Oct-10 5:05 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 15-Oct-10 | Market Purchase | 2,301,390 | $1.78 | $4,094,050.00 | 38% 6.07M to 8.37M | 116% |
| 20-Sep-10 5:17 PM View: ![]() | Medivation, Inc. (MDVN) | 17-Sep-10 | Market Purchase | 8,823 | $11.49 | $101,376.00 | < 1% 3.74M to 3.75M | 805% |
| 20-Sep-10 5:17 PM View: ![]() | Medivation, Inc. (MDVN) | 16-Sep-10 | Market Purchase | 20,827 | $11.49 | $239,242.00 | < 1% 3.72M to 3.74M | 806% |
| 20-Sep-10 5:14 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 16-Sep-10 | Market Purchase | 8,000 | $1.78 | $14,240.00 | < 1% 6.07M to 6.07M | 116% |
| 16-Sep-10 5:28 PM View: ![]() | Medivation, Inc. (MDVN) | 14-Sep-10 | Market Purchase | 31,469 | $11.47 | $361,081.00 | < 1% 3.69M to 3.72M | 807% |
| 14-Sep-10 8:47 PM View: ![]() | Medivation, Inc. (MDVN) | 13-Sep-10 | Market Purchase | 3,400 | $11.50 | $39,100.00 | < 1% 3.69M to 3.69M | 805% |
| 14-Sep-10 8:47 PM View: ![]() | Medivation, Inc. (MDVN) | 10-Sep-10 | Market Purchase | 178,285 | $11.44 | $2,040,270.00 | 5% 3.51M to 3.69M | 809% |
| 14-Sep-10 5:29 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 10-Sep-10 | Market Purchase | 25,000 | $1.80 | $45,000.00 | < 1% 6.04M to 6.07M | 113% |
| 03-Sep-10 5:00 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 01-Sep-10 | Market Purchase | 25,000 | $1.74 | $43,500.00 | < 1% 6.02M to 6.04M | 121% |
| 31-Aug-10 5:04 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 30-Aug-10 | Market Purchase | 25,000 | $1.77 | $44,250.00 | < 1% 5.99M to 6.02M | 117% |
| 31-Aug-10 5:04 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 27-Aug-10 | Market Purchase | 6,000 | $1.75 | $10,500.00 | < 1% 5.98M to 5.99M | 119% |
| 27-Aug-10 5:12 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 26-Aug-10 | Market Purchase | 15,700 | $1.75 | $27,475.00 | < 1% 5.97M to 5.98M | 119% |
| 27-Aug-10 5:12 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 25-Aug-10 | Market Purchase | 17,400 | $1.70 | $29,580.00 | < 1% 5.95M to 5.97M | 126% |
| 25-Aug-10 4:50 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 24-Aug-10 | Market Purchase | 34,900 | $1.73 | $60,377.00 | < 1% 5.92M to 5.95M | 122% |
| 25-Aug-10 4:50 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 23-Aug-10 | Market Purchase | 27,000 | $1.79 | $48,330.00 | < 1% 5.89M to 5.92M | 115% |
| 23-Aug-10 5:10 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 20-Aug-10 | Market Purchase | 4,000 | $1.77 | $7,080.00 | < 1% 5.89M to 5.89M | 117% |
| 23-Aug-10 5:10 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 19-Aug-10 | Market Purchase | 16,000 | $1.79 | $28,640.00 | < 1% 5.87M to 5.89M | 115% |
| 18-Aug-10 5:18 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 17-Aug-10 | Market Purchase | 5,000 | $1.80 | $9,000.00 | < 1% 5.86M to 5.87M | 113% |
| 18-Aug-10 5:18 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 16-Aug-10 | Market Purchase | 35,000 | $1.86 | $65,100.00 | < 1% 5.83M to 5.86M | 107% |
| 16-Aug-10 5:12 PM View: ![]() | Anadys Pharmaceuticals Inc. (ANDS) | 12-Aug-10 | Market Purchase | 32,500 | $1.94 | $63,050.00 | < 1% 5.8M to 5.83M | 98% |